COVID-19 Diagnostic Testing For All - Using Non-Dilutive Saliva Sample Collection, Stabilization and Ambient Transport Devices Article Swipe
Yuan J Carrington
,
Justin Orlino
,
Alex Romero
,
Jessica Gustin
,
Mahssa Rezaei
,
Elizabeth Greene
,
Summer Rose
,
Ramani A. Aiyer
,
Shanavaz Nasarabadi
·
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1101/2021.01.20.20243782
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1101/2021.01.20.20243782
COVID-19 testing is not accessible for millions during this pandemic despite our best efforts. Without greatly expanded testing of asymptomatic individuals, contact tracing and subsequent isolation of spreaders remains as a means for control. In an effort to increase RT-PCR assay testing for the presence of the novel beta-coronavirus SARS-CoV-2 as well as improve sample collection safety, GenTegra LLC has introduced two products for saliva collection and viral RNA stabilization: GTR-STM™ (GenTegra Saliva Transport Medium) and GTR-STMdk™ (GenTegra Saliva Transport Medium Direct to PCR). Both products contain a proprietary formulation based on GenTegra’s novel “Active Chemical Protection™” (ACP) technology that gives non-dilutive, error-free saliva sample collection using RNA stabilization chemicals already dried in the collection tube. GTR-STM can be used for safer saliva-based sample collection at home (or at a test site). Following saliva collection, the sample-containing GTR-STM can be kept at ambient temperature during shipment to an authorized CLIA lab for analysis. SARS-CoV-2 viral RNA in GTR-STM is stable for over a month at ambient temperature, easily surviving the longest transit times from home to lab. GTR-STM enhances patient comfort, convenience, compliance and reduces infectious virus exposure to essential medical and lab professionals. Alternatively, the GTR-STMdk direct-into-PCR product can be used to improve lab throughput and reduce reagent costs for saliva sample collection and testing at any lab site with access to refrigeration. GTR-STMdk reduces lab process time by 25% and reagent costs by 30% compared to other approaches. Since GTR-STMdk retains SARS-CoV-2 viral RNA stability for three days at ambient temperature, it is optimized for lab test site rather than at home saliva collection. SARS-COV-2 viral RNA levels as low as 0.4 genome equivalents/uL are detected in saliva samples using GTR-STMdk. The increased sensitivity of SARS-CoV-2 detection can expand COVID-19 testing to include asymptomatic individuals using pooled saliva. One Sentence Summary GTR-STM and Direct-into-PCR GTR-STMdk offer substantive improvements in SARS-CoV-2 viral RNA stability, safety, and RT-PCR process efficiency for COVID-19 testing by using a non-dilutive saliva sample collection system for individuals at home or onsite respectively.
Related Topics
Concepts
Coronavirus disease 2019 (COVID-19)
Saliva
Sample (material)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
2019-20 coronavirus outbreak
Medicine
Virology
Chromatography
Chemistry
Internal medicine
Outbreak
Disease
Infectious disease (medical specialty)
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1101/2021.01.20.20243782
- https://www.medrxiv.org/content/medrxiv/early/2021/01/25/2021.01.20.20243782.full.pdf
- OA Status
- green
- Cited By
- 3
- References
- 23
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3124088323
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3124088323Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1101/2021.01.20.20243782Digital Object Identifier
- Title
-
COVID-19 Diagnostic Testing For All - Using Non-Dilutive Saliva Sample Collection, Stabilization and Ambient Transport DevicesWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2021Year of publication
- Publication date
-
2021-01-25Full publication date if available
- Authors
-
Yuan J Carrington, Justin Orlino, Alex Romero, Jessica Gustin, Mahssa Rezaei, Elizabeth Greene, Summer Rose, Ramani A. Aiyer, Shanavaz NasarabadiList of authors in order
- Landing page
-
https://doi.org/10.1101/2021.01.20.20243782Publisher landing page
- PDF URL
-
https://www.medrxiv.org/content/medrxiv/early/2021/01/25/2021.01.20.20243782.full.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.medrxiv.org/content/medrxiv/early/2021/01/25/2021.01.20.20243782.full.pdfDirect OA link when available
- Concepts
-
Coronavirus disease 2019 (COVID-19), Saliva, Sample (material), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 2019-20 coronavirus outbreak, Medicine, Virology, Chromatography, Chemistry, Internal medicine, Outbreak, Disease, Infectious disease (medical specialty)Top concepts (fields/topics) attached by OpenAlex
- Cited by
-
3Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2, 2024: 1Per-year citation counts (last 5 years)
- References (count)
-
23Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3124088323 |
|---|---|
| doi | https://doi.org/10.1101/2021.01.20.20243782 |
| ids.doi | https://doi.org/10.1101/2021.01.20.20243782 |
| ids.mag | 3124088323 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/33532800 |
| ids.openalex | https://openalex.org/W3124088323 |
| fwci | 0.0731437 |
| type | preprint |
| title | COVID-19 Diagnostic Testing For All - Using Non-Dilutive Saliva Sample Collection, Stabilization and Ambient Transport Devices |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11754 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9970999956130981 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | SARS-CoV-2 detection and testing |
| topics[1].id | https://openalex.org/T11775 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.995199978351593 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2741 |
| topics[1].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[1].display_name | COVID-19 diagnosis using AI |
| topics[2].id | https://openalex.org/T10118 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9940000176429749 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2725 |
| topics[2].subfield.display_name | Infectious Diseases |
| topics[2].display_name | SARS-CoV-2 and COVID-19 Research |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C3008058167 |
| concepts[0].level | 4 |
| concepts[0].score | 0.7845080494880676 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[0].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[1].id | https://openalex.org/C504460877 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6876553893089294 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q155925 |
| concepts[1].display_name | Saliva |
| concepts[2].id | https://openalex.org/C198531522 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6058309078216553 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q485146 |
| concepts[2].display_name | Sample (material) |
| concepts[3].id | https://openalex.org/C3007834351 |
| concepts[3].level | 5 |
| concepts[3].score | 0.585576593875885 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q82069695 |
| concepts[3].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| concepts[4].id | https://openalex.org/C3006700255 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5451383590698242 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q81068910 |
| concepts[4].display_name | 2019-20 coronavirus outbreak |
| concepts[5].id | https://openalex.org/C71924100 |
| concepts[5].level | 0 |
| concepts[5].score | 0.3508799970149994 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[5].display_name | Medicine |
| concepts[6].id | https://openalex.org/C159047783 |
| concepts[6].level | 1 |
| concepts[6].score | 0.27348703145980835 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[6].display_name | Virology |
| concepts[7].id | https://openalex.org/C43617362 |
| concepts[7].level | 1 |
| concepts[7].score | 0.2384391725063324 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q170050 |
| concepts[7].display_name | Chromatography |
| concepts[8].id | https://openalex.org/C185592680 |
| concepts[8].level | 0 |
| concepts[8].score | 0.16734129190444946 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[8].display_name | Chemistry |
| concepts[9].id | https://openalex.org/C126322002 |
| concepts[9].level | 1 |
| concepts[9].score | 0.1434108018875122 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[9].display_name | Internal medicine |
| concepts[10].id | https://openalex.org/C116675565 |
| concepts[10].level | 2 |
| concepts[10].score | 0.07789811491966248 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q3241045 |
| concepts[10].display_name | Outbreak |
| concepts[11].id | https://openalex.org/C2779134260 |
| concepts[11].level | 2 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[11].display_name | Disease |
| concepts[12].id | https://openalex.org/C524204448 |
| concepts[12].level | 3 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[12].display_name | Infectious disease (medical specialty) |
| keywords[0].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[0].score | 0.7845080494880676 |
| keywords[0].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[1].id | https://openalex.org/keywords/saliva |
| keywords[1].score | 0.6876553893089294 |
| keywords[1].display_name | Saliva |
| keywords[2].id | https://openalex.org/keywords/sample |
| keywords[2].score | 0.6058309078216553 |
| keywords[2].display_name | Sample (material) |
| keywords[3].id | https://openalex.org/keywords/severe-acute-respiratory-syndrome-coronavirus-2 |
| keywords[3].score | 0.585576593875885 |
| keywords[3].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| keywords[4].id | https://openalex.org/keywords/2019-20-coronavirus-outbreak |
| keywords[4].score | 0.5451383590698242 |
| keywords[4].display_name | 2019-20 coronavirus outbreak |
| keywords[5].id | https://openalex.org/keywords/medicine |
| keywords[5].score | 0.3508799970149994 |
| keywords[5].display_name | Medicine |
| keywords[6].id | https://openalex.org/keywords/virology |
| keywords[6].score | 0.27348703145980835 |
| keywords[6].display_name | Virology |
| keywords[7].id | https://openalex.org/keywords/chromatography |
| keywords[7].score | 0.2384391725063324 |
| keywords[7].display_name | Chromatography |
| keywords[8].id | https://openalex.org/keywords/chemistry |
| keywords[8].score | 0.16734129190444946 |
| keywords[8].display_name | Chemistry |
| keywords[9].id | https://openalex.org/keywords/internal-medicine |
| keywords[9].score | 0.1434108018875122 |
| keywords[9].display_name | Internal medicine |
| keywords[10].id | https://openalex.org/keywords/outbreak |
| keywords[10].score | 0.07789811491966248 |
| keywords[10].display_name | Outbreak |
| language | en |
| locations[0].id | doi:10.1101/2021.01.20.20243782 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4306402567 |
| locations[0].source.issn | |
| locations[0].source.type | repository |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | bioRxiv (Cold Spring Harbor Laboratory) |
| locations[0].source.host_organization | https://openalex.org/I2750212522 |
| locations[0].source.host_organization_name | Cold Spring Harbor Laboratory |
| locations[0].source.host_organization_lineage | https://openalex.org/I2750212522 |
| locations[0].license | |
| locations[0].pdf_url | https://www.medrxiv.org/content/medrxiv/early/2021/01/25/2021.01.20.20243782.full.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1101/2021.01.20.20243782 |
| locations[1].id | pmid:33532800 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | medRxiv : the preprint server for health sciences |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/33532800 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:7852251 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | medRxiv |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/7852251 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5009472929 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-1615-5587 |
| authorships[0].author.display_name | Yuan J Carrington |
| authorships[0].countries | IT |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210117106 |
| authorships[0].affiliations[0].raw_affiliation_string | GenTegra, LLC |
| authorships[0].institutions[0].id | https://openalex.org/I4210117106 |
| authorships[0].institutions[0].ror | https://ror.org/0252wp173 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210117106 |
| authorships[0].institutions[0].country_code | IT |
| authorships[0].institutions[0].display_name | Polo d’Innovazione di Genomica |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Yuan Carrington |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | GenTegra, LLC |
| authorships[1].author.id | https://openalex.org/A5097709451 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Justin Orlino |
| authorships[1].countries | IT |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210117106 |
| authorships[1].affiliations[0].raw_affiliation_string | GenTegra, LLC |
| authorships[1].institutions[0].id | https://openalex.org/I4210117106 |
| authorships[1].institutions[0].ror | https://ror.org/0252wp173 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210117106 |
| authorships[1].institutions[0].country_code | IT |
| authorships[1].institutions[0].display_name | Polo d’Innovazione di Genomica |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Justin Orlino |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | GenTegra, LLC |
| authorships[2].author.id | https://openalex.org/A5053304924 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-9343-3352 |
| authorships[2].author.display_name | Alex Romero |
| authorships[2].countries | IT |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210117106 |
| authorships[2].affiliations[0].raw_affiliation_string | GenTegra, LLC |
| authorships[2].institutions[0].id | https://openalex.org/I4210117106 |
| authorships[2].institutions[0].ror | https://ror.org/0252wp173 |
| authorships[2].institutions[0].type | facility |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210117106 |
| authorships[2].institutions[0].country_code | IT |
| authorships[2].institutions[0].display_name | Polo d’Innovazione di Genomica |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Alejandro Romero |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | GenTegra, LLC |
| authorships[3].author.id | https://openalex.org/A5112603835 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Jessica Gustin |
| authorships[3].countries | IT |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210117106 |
| authorships[3].affiliations[0].raw_affiliation_string | GenTegra, LLC |
| authorships[3].institutions[0].id | https://openalex.org/I4210117106 |
| authorships[3].institutions[0].ror | https://ror.org/0252wp173 |
| authorships[3].institutions[0].type | facility |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210117106 |
| authorships[3].institutions[0].country_code | IT |
| authorships[3].institutions[0].display_name | Polo d’Innovazione di Genomica |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Jessica Gustin |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | GenTegra, LLC |
| authorships[4].author.id | https://openalex.org/A5100554095 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Mahssa Rezaei |
| authorships[4].countries | IT |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210117106 |
| authorships[4].affiliations[0].raw_affiliation_string | GenTegra, LLC |
| authorships[4].institutions[0].id | https://openalex.org/I4210117106 |
| authorships[4].institutions[0].ror | https://ror.org/0252wp173 |
| authorships[4].institutions[0].type | facility |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210117106 |
| authorships[4].institutions[0].country_code | IT |
| authorships[4].institutions[0].display_name | Polo d’Innovazione di Genomica |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Mahssa Rezaei |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | GenTegra, LLC |
| authorships[5].author.id | https://openalex.org/A5001641507 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-4952-6834 |
| authorships[5].author.display_name | Elizabeth Greene |
| authorships[5].countries | IT |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210117106 |
| authorships[5].affiliations[0].raw_affiliation_string | GenTegra, LLC |
| authorships[5].institutions[0].id | https://openalex.org/I4210117106 |
| authorships[5].institutions[0].ror | https://ror.org/0252wp173 |
| authorships[5].institutions[0].type | facility |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210117106 |
| authorships[5].institutions[0].country_code | IT |
| authorships[5].institutions[0].display_name | Polo d’Innovazione di Genomica |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Elizabeth Greene |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | GenTegra, LLC |
| authorships[6].author.id | https://openalex.org/A5079935440 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Summer Rose |
| authorships[6].countries | IT |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210117106 |
| authorships[6].affiliations[0].raw_affiliation_string | GenTegra, LLC |
| authorships[6].institutions[0].id | https://openalex.org/I4210117106 |
| authorships[6].institutions[0].ror | https://ror.org/0252wp173 |
| authorships[6].institutions[0].type | facility |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210117106 |
| authorships[6].institutions[0].country_code | IT |
| authorships[6].institutions[0].display_name | Polo d’Innovazione di Genomica |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Summer Rose |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | GenTegra, LLC |
| authorships[7].author.id | https://openalex.org/A5010270454 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Ramani A. Aiyer |
| authorships[7].countries | IT |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210117106 |
| authorships[7].affiliations[0].raw_affiliation_string | GenTegra, LLC |
| authorships[7].institutions[0].id | https://openalex.org/I4210117106 |
| authorships[7].institutions[0].ror | https://ror.org/0252wp173 |
| authorships[7].institutions[0].type | facility |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210117106 |
| authorships[7].institutions[0].country_code | IT |
| authorships[7].institutions[0].display_name | Polo d’Innovazione di Genomica |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Ramani A. Aiyer |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | GenTegra, LLC |
| authorships[8].author.id | https://openalex.org/A5048531542 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-8480-0624 |
| authorships[8].author.display_name | Shanavaz Nasarabadi |
| authorships[8].countries | IT |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210117106 |
| authorships[8].affiliations[0].raw_affiliation_string | GenTegra, LLC |
| authorships[8].institutions[0].id | https://openalex.org/I4210117106 |
| authorships[8].institutions[0].ror | https://ror.org/0252wp173 |
| authorships[8].institutions[0].type | facility |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210117106 |
| authorships[8].institutions[0].country_code | IT |
| authorships[8].institutions[0].display_name | Polo d’Innovazione di Genomica |
| authorships[8].author_position | last |
| authorships[8].raw_author_name | Shanavaz Nasarabadi |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | GenTegra, LLC |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.medrxiv.org/content/medrxiv/early/2021/01/25/2021.01.20.20243782.full.pdf |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | COVID-19 Diagnostic Testing For All - Using Non-Dilutive Saliva Sample Collection, Stabilization and Ambient Transport Devices |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11754 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9970999956130981 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | SARS-CoV-2 detection and testing |
| related_works | https://openalex.org/W3036314732, https://openalex.org/W3009669391, https://openalex.org/W3176864053, https://openalex.org/W4206669628, https://openalex.org/W3171943759, https://openalex.org/W4292098121, https://openalex.org/W3154141118, https://openalex.org/W4388896133, https://openalex.org/W3031607536, https://openalex.org/W3198183218 |
| cited_by_count | 3 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1101/2021.01.20.20243782 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306402567 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | bioRxiv (Cold Spring Harbor Laboratory) |
| best_oa_location.source.host_organization | https://openalex.org/I2750212522 |
| best_oa_location.source.host_organization_name | Cold Spring Harbor Laboratory |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I2750212522 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://www.medrxiv.org/content/medrxiv/early/2021/01/25/2021.01.20.20243782.full.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1101/2021.01.20.20243782 |
| primary_location.id | doi:10.1101/2021.01.20.20243782 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4306402567 |
| primary_location.source.issn | |
| primary_location.source.type | repository |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | bioRxiv (Cold Spring Harbor Laboratory) |
| primary_location.source.host_organization | https://openalex.org/I2750212522 |
| primary_location.source.host_organization_name | Cold Spring Harbor Laboratory |
| primary_location.source.host_organization_lineage | https://openalex.org/I2750212522 |
| primary_location.license | |
| primary_location.pdf_url | https://www.medrxiv.org/content/medrxiv/early/2021/01/25/2021.01.20.20243782.full.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1101/2021.01.20.20243782 |
| publication_date | 2021-01-25 |
| publication_year | 2021 |
| referenced_works | https://openalex.org/W3011926357, https://openalex.org/W3019930912, https://openalex.org/W3036030877, https://openalex.org/W3008294222, https://openalex.org/W3035693076, https://openalex.org/W3087879971, https://openalex.org/W3023118558, https://openalex.org/W3034963396, https://openalex.org/W3024006735, https://openalex.org/W3018166943, https://openalex.org/W3038022415, https://openalex.org/W3035973046, https://openalex.org/W3036057665, https://openalex.org/W3015664205, https://openalex.org/W3015245337, https://openalex.org/W3023614120, https://openalex.org/W3082709677, https://openalex.org/W3048385964, https://openalex.org/W3048499799, https://openalex.org/W3097379551, https://openalex.org/W2022995518, https://openalex.org/W2153300342, https://openalex.org/W4205829018 |
| referenced_works_count | 23 |
| abstract_inverted_index.a | 31, 88, 130, 163, 326 |
| abstract_inverted_index.In | 35 |
| abstract_inverted_index.an | 36, 148 |
| abstract_inverted_index.as | 30, 51, 53, 271, 273 |
| abstract_inverted_index.at | 126, 129, 142, 165, 217, 251, 263, 334 |
| abstract_inverted_index.be | 119, 140, 201 |
| abstract_inverted_index.by | 230, 235, 324 |
| abstract_inverted_index.in | 113, 157, 279, 311 |
| abstract_inverted_index.is | 3, 159, 255 |
| abstract_inverted_index.it | 254 |
| abstract_inverted_index.of | 19, 27, 46, 287 |
| abstract_inverted_index.on | 92 |
| abstract_inverted_index.or | 336 |
| abstract_inverted_index.to | 38, 83, 147, 176, 189, 203, 223, 238, 294 |
| abstract_inverted_index.(or | 128 |
| abstract_inverted_index.0.4 | 274 |
| abstract_inverted_index.25% | 231 |
| abstract_inverted_index.30% | 236 |
| abstract_inverted_index.LLC | 59 |
| abstract_inverted_index.One | 301 |
| abstract_inverted_index.RNA | 69, 108, 156, 246, 269, 314 |
| abstract_inverted_index.The | 284 |
| abstract_inverted_index.and | 24, 67, 76, 184, 192, 207, 215, 232, 305, 317 |
| abstract_inverted_index.any | 218 |
| abstract_inverted_index.are | 277 |
| abstract_inverted_index.can | 118, 139, 200, 290 |
| abstract_inverted_index.for | 6, 33, 43, 64, 121, 152, 161, 211, 248, 257, 321, 332 |
| abstract_inverted_index.has | 60 |
| abstract_inverted_index.lab | 151, 193, 205, 219, 227, 258 |
| abstract_inverted_index.low | 272 |
| abstract_inverted_index.not | 4 |
| abstract_inverted_index.our | 12 |
| abstract_inverted_index.the | 44, 47, 114, 136, 170, 196 |
| abstract_inverted_index.two | 62 |
| abstract_inverted_index.Both | 85 |
| abstract_inverted_index.CLIA | 150 |
| abstract_inverted_index.best | 13 |
| abstract_inverted_index.days | 250 |
| abstract_inverted_index.from | 174 |
| abstract_inverted_index.home | 127, 175, 264, 335 |
| abstract_inverted_index.kept | 141 |
| abstract_inverted_index.lab. | 177 |
| abstract_inverted_index.over | 162 |
| abstract_inverted_index.site | 220, 260 |
| abstract_inverted_index.test | 131, 259 |
| abstract_inverted_index.than | 262 |
| abstract_inverted_index.that | 100 |
| abstract_inverted_index.this | 9 |
| abstract_inverted_index.time | 229 |
| abstract_inverted_index.used | 120, 202 |
| abstract_inverted_index.well | 52 |
| abstract_inverted_index.with | 221 |
| abstract_inverted_index.(ACP) | 98 |
| abstract_inverted_index.PCR). | 84 |
| abstract_inverted_index.Since | 241 |
| abstract_inverted_index.assay | 41 |
| abstract_inverted_index.based | 91 |
| abstract_inverted_index.costs | 210, 234 |
| abstract_inverted_index.dried | 112 |
| abstract_inverted_index.gives | 101 |
| abstract_inverted_index.means | 32 |
| abstract_inverted_index.month | 164 |
| abstract_inverted_index.novel | 48, 94 |
| abstract_inverted_index.offer | 308 |
| abstract_inverted_index.other | 239 |
| abstract_inverted_index.safer | 122 |
| abstract_inverted_index.three | 249 |
| abstract_inverted_index.times | 173 |
| abstract_inverted_index.tube. | 116 |
| abstract_inverted_index.using | 107, 282, 298, 325 |
| abstract_inverted_index.viral | 68, 155, 245, 268, 313 |
| abstract_inverted_index.virus | 187 |
| abstract_inverted_index.Direct | 82 |
| abstract_inverted_index.Medium | 81 |
| abstract_inverted_index.RT-PCR | 40, 318 |
| abstract_inverted_index.Saliva | 73, 79 |
| abstract_inverted_index.access | 222 |
| abstract_inverted_index.during | 8, 145 |
| abstract_inverted_index.easily | 168 |
| abstract_inverted_index.effort | 37 |
| abstract_inverted_index.expand | 291 |
| abstract_inverted_index.genome | 275 |
| abstract_inverted_index.levels | 270 |
| abstract_inverted_index.onsite | 337 |
| abstract_inverted_index.pooled | 299 |
| abstract_inverted_index.rather | 261 |
| abstract_inverted_index.reduce | 208 |
| abstract_inverted_index.saliva | 65, 104, 134, 212, 265, 280, 328 |
| abstract_inverted_index.sample | 55, 105, 124, 213, 329 |
| abstract_inverted_index.site). | 132 |
| abstract_inverted_index.stable | 160 |
| abstract_inverted_index.system | 331 |
| abstract_inverted_index.GTR-STM | 117, 138, 158, 178, 304 |
| abstract_inverted_index.Medium) | 75 |
| abstract_inverted_index.Summary | 303 |
| abstract_inverted_index.Without | 15 |
| abstract_inverted_index.already | 111 |
| abstract_inverted_index.ambient | 143, 166, 252 |
| abstract_inverted_index.contact | 22 |
| abstract_inverted_index.contain | 87 |
| abstract_inverted_index.despite | 11 |
| abstract_inverted_index.greatly | 16 |
| abstract_inverted_index.improve | 54, 204 |
| abstract_inverted_index.include | 295 |
| abstract_inverted_index.longest | 171 |
| abstract_inverted_index.medical | 191 |
| abstract_inverted_index.patient | 180 |
| abstract_inverted_index.process | 228, 319 |
| abstract_inverted_index.product | 199 |
| abstract_inverted_index.reagent | 209, 233 |
| abstract_inverted_index.reduces | 185, 226 |
| abstract_inverted_index.remains | 29 |
| abstract_inverted_index.retains | 243 |
| abstract_inverted_index.safety, | 57, 316 |
| abstract_inverted_index.saliva. | 300 |
| abstract_inverted_index.samples | 281 |
| abstract_inverted_index.testing | 2, 18, 42, 216, 293, 323 |
| abstract_inverted_index.tracing | 23 |
| abstract_inverted_index.transit | 172 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.COVID-19 | 1, 292, 322 |
| abstract_inverted_index.Chemical | 96 |
| abstract_inverted_index.GenTegra | 58 |
| abstract_inverted_index.Sentence | 302 |
| abstract_inverted_index.comfort, | 181 |
| abstract_inverted_index.compared | 237 |
| abstract_inverted_index.control. | 34 |
| abstract_inverted_index.detected | 278 |
| abstract_inverted_index.efforts. | 14 |
| abstract_inverted_index.enhances | 179 |
| abstract_inverted_index.expanded | 17 |
| abstract_inverted_index.exposure | 188 |
| abstract_inverted_index.increase | 39 |
| abstract_inverted_index.millions | 7 |
| abstract_inverted_index.pandemic | 10 |
| abstract_inverted_index.presence | 45 |
| abstract_inverted_index.products | 63, 86 |
| abstract_inverted_index.shipment | 146 |
| abstract_inverted_index.(GenTegra | 72, 78 |
| abstract_inverted_index.Following | 133 |
| abstract_inverted_index.GTR-STMdk | 197, 225, 242, 307 |
| abstract_inverted_index.Transport | 74, 80 |
| abstract_inverted_index.analysis. | 153 |
| abstract_inverted_index.chemicals | 110 |
| abstract_inverted_index.detection | 289 |
| abstract_inverted_index.essential | 190 |
| abstract_inverted_index.increased | 285 |
| abstract_inverted_index.isolation | 26 |
| abstract_inverted_index.optimized | 256 |
| abstract_inverted_index.spreaders | 28 |
| abstract_inverted_index.stability | 247 |
| abstract_inverted_index.surviving | 169 |
| abstract_inverted_index.“Active | 95 |
| abstract_inverted_index.GTR-STMdk. | 283 |
| abstract_inverted_index.GTR-STM™ | 71 |
| abstract_inverted_index.SARS-COV-2 | 267 |
| abstract_inverted_index.SARS-CoV-2 | 50, 154, 244, 288, 312 |
| abstract_inverted_index.accessible | 5 |
| abstract_inverted_index.authorized | 149 |
| abstract_inverted_index.collection | 56, 66, 106, 115, 125, 214, 330 |
| abstract_inverted_index.compliance | 183 |
| abstract_inverted_index.efficiency | 320 |
| abstract_inverted_index.error-free | 103 |
| abstract_inverted_index.infectious | 186 |
| abstract_inverted_index.introduced | 61 |
| abstract_inverted_index.stability, | 315 |
| abstract_inverted_index.subsequent | 25 |
| abstract_inverted_index.technology | 99 |
| abstract_inverted_index.throughput | 206 |
| abstract_inverted_index.approaches. | 240 |
| abstract_inverted_index.collection, | 135 |
| abstract_inverted_index.collection. | 266 |
| abstract_inverted_index.formulation | 90 |
| abstract_inverted_index.individuals | 297, 333 |
| abstract_inverted_index.proprietary | 89 |
| abstract_inverted_index.sensitivity | 286 |
| abstract_inverted_index.substantive | 309 |
| abstract_inverted_index.temperature | 144 |
| abstract_inverted_index.GTR-STMdk™ | 77 |
| abstract_inverted_index.GenTegra’s | 93 |
| abstract_inverted_index.asymptomatic | 20, 296 |
| abstract_inverted_index.convenience, | 182 |
| abstract_inverted_index.improvements | 310 |
| abstract_inverted_index.individuals, | 21 |
| abstract_inverted_index.non-dilutive | 327 |
| abstract_inverted_index.saliva-based | 123 |
| abstract_inverted_index.temperature, | 167, 253 |
| abstract_inverted_index.non-dilutive, | 102 |
| abstract_inverted_index.respectively. | 338 |
| abstract_inverted_index.stabilization | 109 |
| abstract_inverted_index.Alternatively, | 195 |
| abstract_inverted_index.equivalents/uL | 276 |
| abstract_inverted_index.professionals. | 194 |
| abstract_inverted_index.refrigeration. | 224 |
| abstract_inverted_index.stabilization: | 70 |
| abstract_inverted_index.Direct-into-PCR | 306 |
| abstract_inverted_index.direct-into-PCR | 198 |
| abstract_inverted_index.Protection™” | 97 |
| abstract_inverted_index.beta-coronavirus | 49 |
| abstract_inverted_index.sample-containing | 137 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 90 |
| corresponding_author_ids | https://openalex.org/A5009472929 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 9 |
| corresponding_institution_ids | https://openalex.org/I4210117106 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8199999928474426 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.3708373 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |